RNS Number : 1700Z
Cirata PLC
12 September 2025
12 September 2025
Cirata plc
("Cirata" or the "Company")
Grant of Awards & PDMR Dealing
Cirata (LSE: CRTA), announces a grant of awards to Stephen Kelly, Chief Executive Officer, under the Company's Share Options Plan (as amended and restated) ("SOP") (the "Award").
The Company's Remuneration Committee has approved the Awards and regards long term incentives as an important part of the remuneration of members of the leadership team to align them with shareholder interests.
Award Details
The Awards shall be structured in the form of equity-based payments. The Award is comprised of 50% share options and 50% performance-based share options. Each performance-based share option entitles the holder to receive one ordinary share of 10p each in the Company ("Ordinary Shares") upon vesting, subject to the achievement of the performance-based conditions detailed below.
· Options over 850,000 Ordinary Shares have been awarded which will vest at the end of June 2027 with an exercise price of 10 pence per share, being the nominal value of the shares on the grant date. This vesting will be subject to the achievement of a closing market price of the Company's Ordinary shares of at least 75 pence on the vesting date.
· Options over 850,000 Ordinary Shares have been awarded which will vest on a quarterly basis to the end of June 2027 with an exercise price of 22 pence per share. The options carry no performance conditions.
In addition
· Options over 700,000 Ordinary Shares have been awarded which will vest on a quarterly basis through to the end of June 2027 with an exercise price of 22 pence per share. The options carry no performance conditions. This grant replaces a prior award, which has now been retired (as detailed below).
The Option strike price of 22[1] pence has been determined as the 60-day volume weighted average price to 9 September 2025.
Any shares issued upon exercise or vesting will rank pari passu with the existing Ordinary Shares of the Company. The Awards are subject to continued service and applicable malus and clawback provisions.
Retirement of Prior Award
Options over 700,000 Ordinary Shares with an exercise price of 86 pence per Ordinary Share, originally awarded to Stephen Kelly upon his appointment to the Company's board of directors on 10 May 2023, have been cancelled and replaced by the SOP Award.
The Awards to Stephen Kelly are summarised in the following schedule.
Option Grants
Award
Number of Options
Total Options held post award
% of Issued Share capital[2]
Strike
Vesting Conditions
Vesting Date
Options
850,000
850,000
0.67%
Nominal Value (10 pence per share)
Closing price of Ordinary Shares of at least 75 pence on vesting date
End of June 2027
Options
850,000
850,000
0.67%
22 pence
None
Quarterly to end June 2027
Options
700,000
700,000
0.55%
22 pence
None
Quarterly to end June 2027
Following the grant of the Awards, Stephen Kelly is beneficially interested in 2,400,000 options over Ordinary Shares in the Company.
In addition, Stephen Kelly is the beneficial owner of 1,802,660 Ordinary Shares, representing 1.43% of the Company's total issued share capital.
For further information, please contact:
Cirata
Via FTI Consulting
Stephen Kelly, Chief Executive Officer
Ricardo Moura, Chief Financial Officer
Daniel Hayes, Investor Relations
FTI Consulting
+44 (0)20 3727 1137
Matt Dixon / Kwaku Aning / Usama Ali
Stifel(Nomad and Joint Broker)
+44 (0)20 7710 7600
Fred Walsh / Brough Ransom / Ben Good
Panmure Liberum(Joint Broker)
+44 (0)20 3100 2000
Max Jones / John More
About Cirata
Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of MAR.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Stephen Kelly
2
Reason for the notification
a)
Position/status
CEO
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Cirata plc
b)
LEI
213800Y1A75RSC698O04
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument Identification code
Ordinary Shares 10p each ISIN: JE00B6Y3DV84
b)
Nature of the transaction
Grant of Share options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
Nil
2,400,000
d)
Aggregated information
n/a
e)
Date of the transaction
11 September 2025
f)
Place of the transaction
Outside a trading venue
[1] 60-day VWAP 21.93 rounded to 22 pence per share
[2] Issued share capital as at the 3 June 2025 consisted of 126,340,251 ordinary shares of ten pence per share each with voting rights admitted to trading. The Company holds no ordinary shares in Treasury.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHPKBBKKBKDDCD
